Ahmed Taha, Ahmed Talha, Kumar Sany, Lodhi Samra Haroon, Akbik Bassel
Internal Medicine, Cleveland Clinic Foundation, Cleveland, USA.
Internal Medicine, University of Maryland Medical Center, Baltimore, USA.
Cureus. 2020 Jun 5;12(6):e8452. doi: 10.7759/cureus.8452.
Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is the underlying cause of a global crisis that the entire world is facing. It is a highly contagious viral infection, which is why social distancing seems to be effective. Its ability to survive on various surfaces and aerosolize necessitates very meticulous precautions, including airborne isolation for severely ill patients requiring mechanical ventilation. However, these patients may need routine diagnostic investigations including chest computed tomography and chest tomography angiogram scans (CT and CTA) to rule out other potential differential diagnoses and guide management. In this case, we focus on the utility of multiorgan ultrasonography (MOU) at the bedside to diagnose and manage pulmonary embolism (PE) in COVID-19 patients.
由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的2019冠状病毒病（COVID-19）大流行是全世界正在面临的全球危机的根本原因。它是一种高度传染性的病毒感染，这就是为什么社交距离似乎有效。它在各种表面存活和气溶胶化的能力使得必须采取非常细致的预防措施，包括对需要机械通气的重症患者进行空气隔离。然而，这些患者可能需要进行常规诊断检查，包括胸部计算机断层扫描和胸部断层血管造影扫描（CT和CTA），以排除其他潜在的鉴别诊断并指导治疗。在这种情况下，我们重点关注床旁多器官超声检查（MOU）在诊断和管理COVID-19患者肺栓塞（PE）方面的效用。
